Page last updated: 2024-11-05

tranexamic acid and Blast Crisis

tranexamic acid has been researched along with Blast Crisis in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Blast Crisis: An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%.

Research Excerpts

ExcerptRelevanceReference
"The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established."5.34Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. ( Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H, 2007)
"The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established."1.34Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. ( Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koseki, M1
Asada, N1
Uryu, H1
Takeuchi, M1
Asakura, H1
Matsue, K1

Other Studies

1 other study available for tranexamic acid and Blast Crisis

ArticleYear
Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
    International journal of hematology, 2007, Volume: 86, Issue:5

    Topics: Acute Disease; Adult; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents; Antithrom

2007